Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Adjuvant ovarian function suppression in premenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2–negative early breast cancer: a multi-center retrospective study

Fig. 5

Disease-free survival difference between underwent OFS or non-OFS among premenopausal patients with CR-score ≤ 1.42. (A) Disease-free survival difference between underwent OFS or non-OFS among premenopausal patients with CR-score ≤ 1.42 before PSM. (B) Disease-free survival difference between underwent OFS or non-OFS among premenopausal patients with CR-score ≤ 1.42 after 1:4 PSM. PSM, propensity score matching; OFS, ovarian function suppression; CR-score, composite recurrence risk score

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us